Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
4226
DELISTED
Aerie Pharmaceuticals
AERI
| $1.46M | ﹤0.01% |
127,814
-78,784
| -38% | -$1.15M |
|
|
LICY.WS
4227
CALL
DELISTED
Li-Cycle Holdings Corp. Redeemable Warrants, each whole warrant exercisable for one Common Share at
LICY.WS
| $1.46M | ﹤0.01% |
+606,349
| New | +$1.11M |
|
|
MAG
4228
DELISTED
MAG Silver
MAG
| $1.45M | ﹤0.01% |
+89,753
| New | +$1.68M |
|
|
TMAC
4229
DELISTED
The Music Acquisition Corporation
TMAC
| $1.45M | ﹤0.01% |
149,474
-3,503
| -2% | -$33.9K |
|
|
TVTY
4230
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.45M | ﹤0.01% |
62,952
-44,076
| -41% | -$1.05M |
|
|
IDEX
4231
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $1.45M | ﹤0.01% |
5,889
+4,139
| +237% | +$1.21M |
|
4232
PUT
Johnson Controls International
JCI
$93.1B
| $1.44M | ﹤0.01% |
21,200
+2,000
| +10% | +$144K |
|
|
PRST
4233
DELISTED
Presto Technologies, Inc. Common Stock
PRST
| $1.44M | ﹤0.01% |
144,312
+16,100
| +13% | +$160K |
|
4234
LG Display
LPL
$3.23B
| $1.44M | ﹤0.01% |
181,353
+146,011
| +413% | +$1.34M |
|
4235
MediciNova
MNOV
$64M
| $1.44M | ﹤0.01% |
380,019
-299,784
| -44% | -$1.14M |
|
4236
Digital Turbine
APPS
$1.15B
| $1.44M | ﹤0.01% |
20,926
-187,213
| -90% | -$11.6M |
|
4237
PUT
Invesco
IVZ
$14.1B
| $1.44M | ﹤0.01% |
+59,700
| New | +$1.49M |
|
4238
CALL
AstraZeneca
AZN
$241B
| $1.44M | ﹤0.01% |
+11,950
| New | +$1.39M |
|
4239
CALL
New Oriental
EDU
$8.96B
| $1.44M | ﹤0.01% |
+70,000
| New | +$2.22M |
|
4240
PUT
Cemex
CX
$16.8B
| $1.43M | ﹤0.01% |
+200,000
| New | +$1.58M |
|
4241
HCI Group
HCI
$2.28B
| $1.43M | ﹤0.01% |
12,950
-13,026
| -50% | -$1.36M |
|
|
FOLD
4242
PUT
DELISTED
Amicus Therapeutics
FOLD
| $1.43M | ﹤0.01% |
+150,000
| New | +$1.53M |
|
|
SVM
4243
Silvercorp Metals
SVM
$2.26B
| $1.43M | ﹤0.01% |
+375,760
| New | +$1.7M |
|
4244
iShares MSCI USA Value Factor ETF
VLUE
$9.45B
| $1.43M | ﹤0.01% |
+14,213
| New | +$1.48M |
|
4245
PUT
Roper Technologies
ROP
$38.8B
| $1.43M | ﹤0.01% |
+3,200
| New | +$1.53M |
|
|
SFBS
4246
ServisFirst Bancshares
SFBS
$4.97B
| $1.43M | ﹤0.01% |
18,328
-3,543
| -16% | -$254K |
|
|
ALX
4247
Alexander's
ALX
$1.4B
| $1.42M | ﹤0.01% |
5,463
-1,779
| -25% | -$476K |
|
4248
PUT
Insulet
PODD
$11.6B
| $1.42M | ﹤0.01% |
+5,000
| New | +$1.43M |
|
4249
PUT
Diamondback Energy
FANG
$54B
| $1.42M | ﹤0.01% |
15,000
-4,800
| -24% | -$386K |
|
4250
Evolus
EOLS
$403M
| $1.42M | ﹤0.01% |
186,044
+137,136
| +280% | +$1.42M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.